Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bristol-Myers Squibb Company - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BMY
New York
2834
www.bms.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bristol-Myers Squibb Company
Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma
- Jun 8th, 2026 10:36 am
Can MariTide Save Amgen Stock From Its Fading Blockbusters?
- Jun 8th, 2026 7:07 am
Argenx (ARGX) Soars 5.8%: Is Further Upside Left in the Stock?
- Jun 8th, 2026 6:56 am
Is AbbVie Stock The Right Defensive Pick In This Volatile Market?
- Jun 8th, 2026 6:55 am
Mariska Hargitay Partners with Bristol Myers Squibb for "Investigating Myeloma" Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
- Jun 8th, 2026 4:59 am
Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now
- Jun 7th, 2026 8:13 am
SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks
- Jun 6th, 2026 10:11 am
Is Amgen An Undervalued Stock Or Value Trap?
- Jun 5th, 2026 4:55 pm
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know
- Jun 5th, 2026 3:45 pm
Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock
- Jun 5th, 2026 12:20 pm
AGEN Early Access Revenues Signal a New Path Ahead of Approval
- Jun 5th, 2026 12:01 pm
Is Agenus Stock a Hold Amid Valuation and Funding Risks?
- Jun 5th, 2026 11:59 am
AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC
- Jun 5th, 2026 11:54 am
Early Detection in Brazil Is a Game Changer for Lung Cancer Care
- Jun 5th, 2026 5:29 am
How Investors May Respond To Bristol Myers Squibb (BMY) Winning EU Nod For First-Line Opdivo Regimen
- Jun 4th, 2026 10:39 pm
3 Value Stocks We Think Twice About
- Jun 4th, 2026 2:13 pm
REGN Expands Cancer Deal With CytomX for Bispecific Therapeutics
- Jun 4th, 2026 11:25 am
Arcus, Bristol Myers Team Up to Advance Kidney Cancer Study
- Jun 4th, 2026 9:53 am
Bristol-Myers Squibb Cancer Wins Test Investor Patience On Valuation
- Jun 4th, 2026 4:11 am
Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?
- Jun 4th, 2026 12:50 am
Scroll